29 results
8-K
EX-99.1
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
7:18am
investment in Verona Pharma underscores Oaktree’s commitment to provide flexible capital solutions to innovative life sciences companies
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
commitment to their roles. The Board of Directors considers that it is entirely appropriate for each of Lisa Deschamps, Martin Edwards, M.D., Anders Ullman … of the additional time commitment and responsibilities of the non-executive directors as the Company has advanced, the Remuneration Committee
8-K
EX-99.1
140y3v mvan64n7kq8u
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-10.1
blpfj6ep6x9btwwer8y
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-10.1
9v0q2zrubdej
17 Oct 22
Entry into a Material Definitive Agreement
6:00am
8-K
EX-1.1
wlk2zgn4ev anugb1mx7
11 Aug 22
Other Events
5:46pm
424B5
56ay932 9uc65c
11 Aug 22
Prospectus supplement for primary offering
5:09pm
424B5
jsl6zunr7eh44ha4
9 Aug 22
Prospectus supplement for primary offering
12:00am
S-3
EX-1.2
1qatcteh2hpbwimwpp
19 Mar 21
Shelf registration
5:23pm
DEF 14A
tgg2c0s
19 Mar 21
Definitive proxy
4:02pm
10-K
sz6pyh
25 Feb 21
Annual report
8:29am
10-K
EX-10.20
9wty35cp
25 Feb 21
Annual report
8:29am
6-K
EX-1
tzn798
30 Dec 20
Current report (foreign)
4:11pm